Nuzenio

Ani Pharmaceuticals Reports

Ani Pharmaceuticals Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 21 latest news signals 12 publisher sources 100/100 entity strength

Latest news

ANI Pharmaceuticals (NASDAQ:ANIP) Announces Earnings Results - MarketBeatMarketBeat · Sat, 08 Aug 2026 02:19:20 GMTANI Pharmaceuticals Announces Q2 2026 Earnings and Releases Updated Investor Presentation - Kalkine MediaKalkine Media · Fri, 07 Aug 2026 18:47:09 GMTANI Pharmaceuticals (NASDAQ:ANIP) Releases FY 2026 Earnings Guidance - MarketBeatMarketBeat · Fri, 07 Aug 2026 11:29:36 GMTANI Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 11:16:42 GMTANI Pharmaceuticals’s (NASDAQ:ANIP) Q2 CY2026 Sales Beat Estimates But Stock Drops On Weak Guidance - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 11:12:00 GMTANI Pharmaceuticals 2026: Revenue $266.04M, EPS $1.05— 10-Q Summary - TradingViewTradingView · Fri, 07 Aug 2026 11:11:00 GMTANI Pharmaceuticals Reports Second-Quarter 2026 Results, Raises Cortrophin Gel Guidance and Reaffirms Full-Year Outlook - Quiver QuantitativeQuiver Quantitative · Fri, 07 Aug 2026 11:00:00 GMTANI Pharmaceuticals reports Q2 adjusted EPS $2.21, consensus $2.04 - TipRanksTipRanks · Fri, 07 Aug 2026 10:58:39 GMT

Timeline

Sat, 08 Aug 2026 02:19:20 GMTANI Pharmaceuticals (NASDAQ:ANIP) Announces Earnings Results - MarketBeat
Fri, 07 Aug 2026 18:47:09 GMTANI Pharmaceuticals Announces Q2 2026 Earnings and Releases Updated Investor Presentation - Kalkine Media
Fri, 07 Aug 2026 11:29:36 GMTANI Pharmaceuticals (NASDAQ:ANIP) Releases FY 2026 Earnings Guidance - MarketBeat
Fri, 07 Aug 2026 11:16:42 GMTANI Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise - Yahoo Finance
Fri, 07 Aug 2026 11:12:00 GMTANI Pharmaceuticals’s (NASDAQ:ANIP) Q2 CY2026 Sales Beat Estimates But Stock Drops On Weak Guidance - The Globe and Mail
Fri, 07 Aug 2026 11:11:00 GMTANI Pharmaceuticals 2026: Revenue $266.04M, EPS $1.05— 10-Q Summary - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ani Pharmaceuticals Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.